Skip to main content
. 2019 Jun 1;199(11):1421–1431. doi: 10.1164/rccm.201806-1100OC

Figure 5.

Figure 5.

Percentage of participants with improvement on the Global Impression of Change scales (modified intent-to-treat population): (A) Patient Global Impression of Change scale and (B) Clinical Global Impression of Change scale results. *P < 0.05 and P < 0.0001 for difference between solriamfetol and placebo. CGI-C = Clinical Global Impression of Change scale; PGI-C = Patient Global Impression of Change scale.